These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 27452317)

  • 1. The US etonogestrel implant mandatory clinical training and active monitoring programs: 6-year experience.
    Creinin MD; Kaunitz AM; Darney PD; Schwartz L; Hampton T; Gordon K; Rekers H
    Contraception; 2017 Feb; 95(2):205-210. PubMed ID: 27452317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real world data on Nexplanon® procedure-related events: final results from the Nexplanon Observational Risk Assessment study (NORA).
    Reed S; Do Minh T; Lange JA; Koro C; Fox M; Heinemann K
    Contraception; 2019 Jul; 100(1):31-36. PubMed ID: 30980829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved duration.
    McNicholas C; Swor E; Wan L; Peipert JF
    Am J Obstet Gynecol; 2017 Jun; 216(6):586.e1-586.e6. PubMed ID: 28147241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion-a randomized controlled equivalence trial.
    Hognert H; Kopp Kallner H; Cameron S; Nyrelli C; Jawad I; Heller R; Aronsson A; Lindh I; Benson L; Gemzell-Danielsson K
    Hum Reprod; 2016 Nov; 31(11):2484-2490. PubMed ID: 27664217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of immediate postpartum compared to delayed postpartum and interval etonogestrel contraceptive implant insertion on removal rates for bleeding.
    Ireland LD; Goyal V; Raker CA; Murray A; Allen RH
    Contraception; 2014 Sep; 90(3):253-8. PubMed ID: 24973904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Immediate Postpartum Etonogestrel Implant Insertion and Venous Thromboembolism.
    Floyd JL; Beasley AD; Swaim LS; Turrentine MA; Nijjar JB
    Obstet Gynecol; 2020 Jun; 135(6):1275-1280. PubMed ID: 32459418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the etonogestrel implant and levonorgestrel intrauterine device beyond the U.S. Food and Drug Administration-approved duration.
    McNicholas C; Maddipati R; Zhao Q; Swor E; Peipert JF
    Obstet Gynecol; 2015 Mar; 125(3):599-604. PubMed ID: 25730221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of etonogestrel implant beyond approved duration: prolonged contraceptive effectiveness.
    Ribeiro BC; Nogueira-Silva C; Afonso H; Silva PO; Reis ID
    Eur J Contracept Reprod Health Care; 2018 Aug; 23(4):309-310. PubMed ID: 30203680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etonogestrel implant migration to the vasculature, chest wall, and distant body sites: cases from a pharmacovigilance database.
    Kang S; Niak A; Gada N; Brinker A; Jones SC
    Contraception; 2017 Dec; 96(6):439-445. PubMed ID: 28867440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bleeding related to etonogestrel subdermal implant in a US population.
    Casey PM; Long ME; Marnach ML; Bury JE
    Contraception; 2011 May; 83(5):426-30. PubMed ID: 21477684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Insertion problems, removal problems, and contraception failures with Implanon].
    Bensouda-Grimaldi L; Jonville-Béra AP; Beau-Salinas F; Llabres S; Autret-Leca E;
    Gynecol Obstet Fertil; 2005 Dec; 33(12):986-90. PubMed ID: 16321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing of Etonogestrel Implant Insertion After Dilation and Evacuation: A Randomized Controlled Trial.
    Cowett AA; Ali R; Cooper MA; Evans M; Conzuelo G; Cremer M
    Obstet Gynecol; 2018 May; 131(5):856-862. PubMed ID: 29630023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot study of a novel, alternative subdermal scapular insertion site for the etonogestrel contraceptive implant.
    Clure C; Sheeder J; Lazorwitz A
    Contraception; 2024 Jul; 135():110442. PubMed ID: 38552822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etonogestrel contraceptive implant-associated secondary anorgasmia.
    Chapa HO; Ramirez A; Dawson D
    Contraception; 2017 Oct; 96(4):254-256. PubMed ID: 28666796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Removal of a Nonpalpable Etonogestrel Implant With Preprocedure Ultrasonography and Modified Vasectomy Clamp.
    Chen MJ; Creinin MD
    Obstet Gynecol; 2015 Nov; 126(5):935-938. PubMed ID: 26444124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Migration of etonogestrel subcutaneous contraceptive implants: systematic review and recommendations for practice.
    Guilbert É; Arguin H; Bélanger M
    Eur J Contracept Reprod Health Care; 2024 Jun; 29(3):115-130. PubMed ID: 38712717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difficult removal of subdermal contraceptive implants: a multidisciplinary approach involving a peripheral nerve expert.
    Odom EB; Eisenberg DL; Fox IK
    Contraception; 2017 Aug; 96(2):89-95. PubMed ID: 28583591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathy associated with etonogestrel implant insertion.
    Brown M; Britton J
    Contraception; 2012 Nov; 86(5):591-3. PubMed ID: 22770789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Contraceptive implants--aberrations from insertion and removal procedures].
    Jørgensen NP
    Tidsskr Nor Laegeforen; 2010 Apr; 130(7):733-4. PubMed ID: 20379334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of carbamazepine on etonogestrel concentrations in contraceptive implant users.
    Lazorwitz A; Davis A; Swartz M; Guiahi M
    Contraception; 2017 Jun; 95(6):571-577. PubMed ID: 28288788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.